The cash flow of Legence Corp. over the past 3 years
Chart Legence Corp.: operating cash flow, capital expenditures, free cash flow, fiscal 2023–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, Legence Corp.'s operating cash flow was $256.87M and its capital expenditures $37.94M, leaving free cash flow of $218.93M. Free cash flow was above zero in all 3 years shown. It ranged from $10.26M in fiscal 2024 to $218.93M in fiscal 2025. Capital expenditures were highest in fiscal 2025, at $37.94M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $256.87M | $37.94M | $218.93M |
| 2024ended Dec 31, 2024 | $29.27M | $19.01M | $10.26M |
| 2023ended Dec 31, 2023 | $33.92M | $17.07M | $16.84M |
Fiscal years as Legence Corp. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Legence Corp.
- The revenue of Legence Corp.
- The profitability of Legence Corp.
- All of Legence Corp.'s financials, charted
Companies of a similar size
- ELVNENLIVEN THERAPEUTICS, INC.
- BCCBoise Cascade Company
- NBTBNBT BANCORP INC
- WLYJOHN WILEY & SONS, INC.
- REZIResideo Technologies, Inc.
Not investment advice. This page shows what Legence Corp. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.